Pieris are easy-to-grow and cold-hardy evergreen shrubs with dark fingered foliage that is attractive all year round. This plant (also known as the andromeda bush or the lily-of-the-valley bush) ...

Shares drop after the company announces the pricing details of a common stock offering. However, investors learned today that the company succeeded in selling 5.5 million shares to the public, but the ...

My first spring catalog has come. The excitement at our house is at a winter high — thinking of all of the green that comes with spring and the opportunities to add to my landscape. I have marked ...

The signing of a lucrative collaboration deal causes the share price to jump. This deal provides Pieris with an up-front payment of $30 million and the ability to earn up to $1.2 billion in milestone ...

Pieris Pharmaceuticals is trimming the fat, putting its lead immuno-oncology asset on the chopping block to make more room for its AstraZeneca partnership. With the readout for the ...

Pieris received a grant of $17 million from the Bavarian Ministry of Economic Affairs for a drug to treat lung scarring in COVID sufferers. Shares of Pieris Pharmaceuticals (PIRS) jumped on Friday ...

FREISING-WEIHENSTEPHAN, Germany, January 4 /PRNewswire/ -- Pieris AG today announced the appointment of Stephen S. Yoder as CEO with immediate effect. Mr. Yoder takes over the position from interim ...

BOSTON, MA / ACCESSWIRE / November 2, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® ...

Under the collaboration agreement, AstraZeneca will make an upfront payment of $57.5 million and near-term milestone payments of $12.5 million to Pieris once it initiated Phase 1 trial for PRS-060.

View post: Amazon is selling $47 storage bins that 'help you fit so much more on your shelves' for just $26 Under the terms, Seagen bought 3.7 million Pieris shares at $3.51 each, the companies said ...

Shares of Pieris Pharmaceuticals Inc. rocketed 57.3% on massive volume in afternoon trading Tuesday, after the Boston-based biotechnology company announced a respiratory and ophthalmology ...